Drug therapy of primary pulmonary hypertension
Drug therapy of primary pulmonary hypertension
About this item
Full title
Author / Creator
Publisher
New Zealand: Wolters Kluwer Health, Inc
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Wolters Kluwer Health, Inc
Subjects
More information
Scope and Contents
Contents
Primary pulmonary hypertension (PPH) is a rare but life-threatening disease. Median survival, from the time of diagnosis, is considered to be 2.8 years. However, therapeutic medical advances over the past 2 decades have resulted in significant improvements in quality of life and survival in patients with PPH. Because pulmonary vasoconstriction, end...
Alternative Titles
Full title
Drug therapy of primary pulmonary hypertension
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A199397174
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A199397174
Other Identifiers
ISSN
1175-3277
DOI
10.2165/00129784-200404020-00002
